Internal validity (IV) criteria | |
A | Method of randomisation adequate (eg, random number table)? | 1 |
B | Treatment allocation concealed? | 1 |
C | Groups similar at baseline regarding age, gender, history of back pain, area of work, pregnancy, nurse grade and baseline measures? | 1 |
D | Co-interventions avoided or similar? | 1 |
E | i) Drop-out/withdrawal individuals adequately described? | 0.5 |
ii) Drop-out rate acceptable (<20% for short-term and <30% for long-term follow-up)? | 0.5 |
F | Intention to treat method of analysis (irrespective of compliance, change in group status)? | 1 |
IV score | 6 |
| |
Descriptive quality (DQ) criteria | |
G | Eligibility criteria specified? | 1 |
H | Index and control interventions explicitly described? | 1 |
I | i) Short-term follow-up measurement (⩽3 months post initiation of intervention)? | 0.5 |
ii) Long-term follow-up measurement (>3 months post initiation of intervention)? | 0.5 |
J | Sample size for each group described at randomisation and all important outcome assessments? | 1 |
K | Point estimates and measures of variability presented for primary and secondary outcome measures? | 1 |
L | i) Sampling method adequate? | 0.5 |
ii) Participation rate adequate (>80%)? | 0.5 |
DQ score | 6 |
| |
Total score (IV+DQ scores) | 12 |